Recruiting

Observational Study

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT07294703

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survey

Study Details

Brief summary:

The purpose of this study is to learn more about risks and outcomes of breast cancer in people with different backgrounds. Tissue and blood will be collected from participants for research purposes. Participants will complete questionnaires during their standard medical care. The study will not provide treatment for cancer or any other condition.

Conditions

Breast Cancer

Study ID

NCT07294703

Start date

Dec 8, 2025

Status verified date

Apr, 2026

Completion date

Dec 8, 2031

Anticipated

Primary completion date

Dec 8, 2031

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Women 18 years and older who are patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient seen at MSK undergoing surgery.

Inclusion Criteria:

A patient cannot be considered eligible for this study unless the following conditions are met.

  • Patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient who is a surgical candidate seen at MSK.
  • Women 18 years of age and older are eligible to participate in the study.

Exclusion Criteria:

  • Patients presenting with a suspicious breast mass or breast cancer less than 1 cm.
  • Patients presenting to clinic with only microinvasion
  • Patients who are less than 18 years of age
  • Patients unable to complete the survey, including IDMC patients.

Study Design

Enrollment

750 participants

Anticipated

Interventions and Outcome Measures

Arms

Participants with a suspicious breast finding or new breast cancer diagnosis

Participants with a suspicious breast finding who present to breast radiology at MSK for biopsy or a participants with a new breast cancer diagnosis who is a surgical candidate seen at MSK.

Interventions

Survey

Complete surveys:

  • Baseline (within 6 months of enrollment)
  • 1st follow-up survey (approx. 6 months to 12 months)
  • 2nd follow-up survey and/or blood collection (approx. 3 years +/- 6 months)
  • 3rd follow-up survey and/or blood collection (approx. 5 years +/- 6 months)

Primary outcome measure

  • Recurrence Free Survival/RFS [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Neha Goel, MD, MPH

646-888-4298goeln1@mskcc.org

George Plitas, MD

646-888-5368PlitasG@mskcc.org

Locations

Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities)

Recruiting

Basking Ridge, New Jersey, United States, 07920

Contacts

Neha Goel, MD, MPH

646-888-4298

Memorial Sloan Kettering Monmouth (All Protocol Activities)

Recruiting

Middletown, New Jersey, United States, 07748

Contacts

Neha Goel, MD, MPH

646-888-4298

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Recruiting

Montvale, New Jersey, United States, 07645

Contacts

Neha Goel, MD, MPH

646-888-4298

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)

Recruiting

Commack, New York, United States, 11725

Contacts

Neha Goel, MD, MPH

646-888-4298

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

Recruiting

Harrison, New York, United States, 10604

Contacts

Neha Goel, MD, MPH

646-888-4298

Memorial Sloan Kettering Cancer Center (All Protocol Activites)

Recruiting

New York, New York, United States, 10065

Contacts

Neha Goel, MD, MPH

646-888-4298

Memorial Sloan Kettering Nassau (Limited Protocol Activites)

Recruiting

Rockville Centre, New York, United States, 11553

Contacts

Neha Goel, MD, MPH

646-888-4298

More Information

Sponsor

Memorial Sloan Kettering Cancer Center

Last update posted

Apr 17, 2026

Last verified

Apr, 2026

Keywords

  • Breast cancer
  • Memorial Sloan Kettering Cancer Center
  • 25-335

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2026-04-17.